Growing Prevalence of Hemoglobinopathy Disorders and Particularly Sickle Cell Anemia Boost the Growth of the Global Hemoglobinopathies Market

Hemoglobinopathies are genetic disorders caused by an abnormal structure or production of the hemoglobin molecule, sickle cell anemia being the most common of the disorders. Due to the growing prevalence of hemoglobinopathies, the world is seeing more advanced diagnostics and therapies, as well as an increasing number of awareness programs about these disorders. All of these factors have spurred growth in the global hemoglobinopathies market, with further growth expected in both developing and developed countries, as a result of better health care infrastructure.

PR Inside, February 2017